Sources: CBO Score Of OTC Monograph Could Be Sign Of Movement

By Beth Wang / December 13, 2018 at 1:16 PM
The Congressional Budget Office’s Dec. 7 publication of its cost estimate for the Senate’s over-the-counter monograph reform bill bolstered stakeholders’ hopes that the bill might pass the upper chamber before the end of the lame-duck session. An industry lawyer says it is hard to ignore the timing of the CBO score, which found the bill would have negligible effects on spending. While CBO is required to prepare cost estimates for all bills that have been reported out of committee, the...

Not a subscriber? Sign up for 30 days free access to exclusive, detailed reporting on drug pricing reforms, Medicaid policy, FDA news and much more.